Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Osmotica Pharmaceuticals management to meet virtually with Truist » 04:55
07/22/21
07/22
04:55
07/22/21
04:55
OSMT

Osmotica Pharmaceuticals

$3.57 /

-0.03 (-0.83%)

Virtual Meetings to be…

Virtual Meetings to be held on July 20-22 hosted by Truist.

ShowHide Related Items >><<
OSMT Osmotica Pharmaceuticals
$3.57 /

-0.03 (-0.83%)

OSMT Osmotica Pharmaceuticals
$3.57 /

-0.03 (-0.83%)

04/06/21 RBC Capital
Osmotica Pharmaceuticals transferred with an Outperform at RBC Capital
12/30/20 Truist
Osmotica Pharmaceuticals price target lowered to $8 from $11 at Truist
OSMT Osmotica Pharmaceuticals
$3.57 /

-0.03 (-0.83%)

Conference/Events
Osmotica Pharmaceuticals management to meet virtually with Truist » 04:55
07/21/21
07/21
04:55
07/21/21
04:55
OSMT

Osmotica Pharmaceuticals

$3.60 /

+0.19 (+5.57%)

Virtual Meetings to be…

Virtual Meetings to be held on July 20-22 hosted by Truist.

ShowHide Related Items >><<
OSMT Osmotica Pharmaceuticals
$3.60 /

+0.19 (+5.57%)

OSMT Osmotica Pharmaceuticals
$3.60 /

+0.19 (+5.57%)

04/06/21 RBC Capital
Osmotica Pharmaceuticals transferred with an Outperform at RBC Capital
12/30/20 Truist
Osmotica Pharmaceuticals price target lowered to $8 from $11 at Truist
OSMT Osmotica Pharmaceuticals
$3.60 /

+0.19 (+5.57%)

Conference/Events
Osmotica Pharmaceuticals management to meet virtually with Truist » 04:55
07/20/21
07/20
04:55
07/20/21
04:55
OSMT

Osmotica Pharmaceuticals

$3.41 /

+0.18 (+5.57%)

Virtual Meetings to be…

Virtual Meetings to be held on July 20-22 hosted by Truist.

ShowHide Related Items >><<
OSMT Osmotica Pharmaceuticals
$3.41 /

+0.18 (+5.57%)

OSMT Osmotica Pharmaceuticals
$3.41 /

+0.18 (+5.57%)

04/06/21 RBC Capital
Osmotica Pharmaceuticals transferred with an Outperform at RBC Capital
12/30/20 Truist
Osmotica Pharmaceuticals price target lowered to $8 from $11 at Truist
OSMT Osmotica Pharmaceuticals
$3.41 /

+0.18 (+5.57%)

Conference/Events
Osmotica Pharmaceuticals management to meet virtually with Truist » 10:23
07/19/21
07/19
10:23
07/19/21
10:23
OSMT

Osmotica Pharmaceuticals

$3.22 /

-0.01 (-0.31%)

Virtual Meetings to be…

Virtual Meetings to be held on July 20-22 hosted by Truist.

ShowHide Related Items >><<
OSMT Osmotica Pharmaceuticals
$3.22 /

-0.01 (-0.31%)

OSMT Osmotica Pharmaceuticals
$3.22 /

-0.01 (-0.31%)

04/06/21 RBC Capital
Osmotica Pharmaceuticals transferred with an Outperform at RBC Capital
12/30/20 Truist
Osmotica Pharmaceuticals price target lowered to $8 from $11 at Truist
OSMT Osmotica Pharmaceuticals
$3.22 /

-0.01 (-0.31%)

Over a month ago
Hot Stocks
Osmotica subsidary RVL Pharmaceuticals expands leadership team with Green » 07:19
06/30/21
06/30
07:19
06/30/21
07:19
OSMT

Osmotica Pharmaceuticals

$3.14 /

-0.435 (-12.18%)

Osmotica Pharmaceuticals…

Osmotica Pharmaceuticals announced that J. Aaron Green will join the leadership team of RVL Pharmaceuticals, the company's wholly owned subsidiary focused on eye care and ocular aesthetics, in the role of Vice President, Sales and Market Development, Aesthetics, effective July 6. J. Aaron Green joins RVL with over 20 years of experience across eye care and medical aesthetics. Most recently, Green was a commercial leader at Galderma for eight years.

ShowHide Related Items >><<
OSMT Osmotica Pharmaceuticals
$3.14 /

-0.435 (-12.18%)

OSMT Osmotica Pharmaceuticals
$3.14 /

-0.435 (-12.18%)

04/06/21 RBC Capital
Osmotica Pharmaceuticals transferred with an Outperform at RBC Capital
12/30/20 Truist
Osmotica Pharmaceuticals price target lowered to $8 from $11 at Truist
07/10/20 Truist
Osmotica Pharmaceuticals price target raised to $11 from $8 at SunTrust
07/09/20 RBC Capital
Osmotica price target raised to $12 from $10 at RBC Capital
OSMT Osmotica Pharmaceuticals
$3.14 /

-0.435 (-12.18%)

  • 14
    Jul
OSMT Osmotica Pharmaceuticals
$3.14 /

-0.435 (-12.18%)

Hot Stocks
Osmotica Pharmaceuticals to sell legacy business to Alora for up to $170M » 06:53
06/25/21
06/25
06:53
06/25/21
06:53
OSMT

Osmotica Pharmaceuticals

$2.84 /

+0.03 (+1.07%)

Osmotica Pharmaceuticals…

Osmotica Pharmaceuticals announced that it has entered into a definitive Purchase and Sale Agreement with Alora Pharmaceuticals, pursuant to which Alora will acquire Osmotica's portfolio of legacy products and its Marietta, Georgia manufacturing facility, for up to $170M. The Boards of Directors of both Osmotica and Alora have approved the transaction, which is expected to close in the third quarter.

ShowHide Related Items >><<
OSMT Osmotica Pharmaceuticals
$2.84 /

+0.03 (+1.07%)

OSMT Osmotica Pharmaceuticals
$2.84 /

+0.03 (+1.07%)

04/06/21 RBC Capital
Osmotica Pharmaceuticals transferred with an Outperform at RBC Capital
12/30/20 Truist
Osmotica Pharmaceuticals price target lowered to $8 from $11 at Truist
07/10/20 Truist
Osmotica Pharmaceuticals price target raised to $11 from $8 at SunTrust
07/09/20 RBC Capital
Osmotica price target raised to $12 from $10 at RBC Capital
OSMT Osmotica Pharmaceuticals
$2.84 /

+0.03 (+1.07%)

  • 14
    Jul
OSMT Osmotica Pharmaceuticals
$2.84 /

+0.03 (+1.07%)

Over a quarter ago
Recommendations
Osmotica Pharmaceuticals transferred with an Outperform at RBC Capital » 16:55
04/06/21
04/06
16:55
04/06/21
16:55
OSMT

Osmotica Pharmaceuticals

$3.34 /

-0.105 (-3.05%)

RBC Capital transferred…

RBC Capital transferred coverage of Osmotica Pharmaceuticals to analyst Daniel Busby, also keeping an Outperform rating and $8 price target on the stock.

ShowHide Related Items >><<
OSMT Osmotica Pharmaceuticals
$3.34 /

-0.105 (-3.05%)

OSMT Osmotica Pharmaceuticals
$3.34 /

-0.105 (-3.05%)

12/30/20 Truist
Osmotica Pharmaceuticals price target lowered to $8 from $11 at Truist
07/10/20 Truist
Osmotica Pharmaceuticals price target raised to $11 from $8 at SunTrust
07/09/20 RBC Capital
Osmotica price target raised to $12 from $10 at RBC Capital
OSMT Osmotica Pharmaceuticals
$3.34 /

-0.105 (-3.05%)

  • 14
    Jul
OSMT Osmotica Pharmaceuticals
$3.34 /

-0.105 (-3.05%)

Earnings
Osmotica Pharmaceuticals reports Q4 EPS (88c), consensus (24c) » 16:18
03/30/21
03/30
16:18
03/30/21
16:18
OSMT

Osmotica Pharmaceuticals

$3.52 /

-0.445 (-11.24%)

Reports Q4 revenue…

Reports Q4 revenue $34.53M, consensus $35.73M. "Throughout the past year, we have made meaningful progress on transforming our business, as highlighted by the approval and launch of Upneeq, the first FDA-approved therapeutic treatment for acquired ptosis in adults. In addition to this important accomplishment, we also expanded the international reach of Upneeq through our licensing transaction with Santen Pharmaceuticals - an exceptional partner - covering the EU and Asia, which we see as a major milestone toward establishing Upneeq as a global brand," stated Brian Markison, CEO.

ShowHide Related Items >><<
OSMT Osmotica Pharmaceuticals
$3.52 /

-0.445 (-11.24%)

OSMT Osmotica Pharmaceuticals
$3.52 /

-0.445 (-11.24%)

12/30/20 Truist
Osmotica Pharmaceuticals price target lowered to $8 from $11 at Truist
07/10/20 Truist
Osmotica Pharmaceuticals price target raised to $11 from $8 at SunTrust
07/09/20 RBC Capital
Osmotica price target raised to $12 from $10 at RBC Capital
OSMT Osmotica Pharmaceuticals
$3.52 /

-0.445 (-11.24%)

  • 14
    Jul
OSMT Osmotica Pharmaceuticals
$3.52 /

-0.445 (-11.24%)

Hot Stocks
Adamas Pharmaceuticals completes acquisition of OSMOLEX ER » 09:16
01/05/21
01/05
09:16
01/05/21
09:16
ADMS

Adamas Pharmaceuticals

$4.52 /

+0.18 (+4.15%)

, OSMT

Osmotica Pharmaceuticals

$4.32 /

+0.22 (+5.37%)

Adamas Pharmaceuticals…

Adamas Pharmaceuticals (ADMS) announced the closing of the settlement of patent litigation with Osmotica Pharmaceutical US, a subsidiary of Osmotica Pharmaceuticals (OSMT) and completes the acquisition of the global rights to OSMOLEX ER. As previously disclosed, the amended Royalty-Backed Loan Agreement with HealthCare Royalty Partners is now effective with the closing of the acquisition of OSOMOLEX ER. Through this acquisition, OSMOLEX ER joins the Adamas portfolio which includes GOCOVRI extended-release capsules for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy with or without concomitant dopaminergic medications. OSMOLEX ER extended-release tablets is FDA-approved for the treatment for Parkinson's disease and drug-induced extrapyramidal reactions in adult patients. According to their Prescribing Information, neither GOCOVRI nor OSMOLEX ER are interchangeable with other amantadine immediate- or extended-release products for their respective approved indications.

ShowHide Related Items >><<
OSMT Osmotica Pharmaceuticals
$4.32 /

+0.22 (+5.37%)

ADMS Adamas Pharmaceuticals
$4.52 /

+0.18 (+4.15%)

ADMS Adamas Pharmaceuticals
$4.52 /

+0.18 (+4.15%)

OSMT Osmotica Pharmaceuticals
$4.32 /

+0.22 (+5.37%)

12/30/20 Truist
Osmotica Pharmaceuticals price target lowered to $8 from $11 at Truist
07/10/20 Truist
Osmotica Pharmaceuticals price target raised to $11 from $8 at SunTrust
07/09/20 RBC Capital
Osmotica price target raised to $12 from $10 at RBC Capital
03/23/20 Wells Fargo
Wells Fargo downgrades Osmotica to Equal Weight, halves price target to $4
OSMT Osmotica Pharmaceuticals
$4.32 /

+0.22 (+5.37%)

ADMS Adamas Pharmaceuticals
$4.52 /

+0.18 (+4.15%)

  • 14
    Jul
  • 09
    Jan
OSMT Osmotica Pharmaceuticals
$4.32 /

+0.22 (+5.37%)

On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 16:20
12/30/20
12/30
16:20
12/30/20
16:20
AZN

AstraZeneca

$50.16 /

+0.26 (+0.52%)

, TSLA

Tesla

$694.65 /

+28.67 (+4.30%)

, OSMT

Osmotica Pharmaceuticals

$4.22 /

-1.07 (-20.23%)

, MVIS

MicroVision

$6.18 /

-0.15 (-2.37%)

, DMTK

DermTech

$35.66 /

+7.53 (+26.77%)

Stocks had a winning day…

ShowHide Related Items >><<
TSLA Tesla
$694.65 /

+28.67 (+4.30%)

OSMT Osmotica Pharmaceuticals
$4.22 /

-1.07 (-20.23%)

MVIS MicroVision
$6.18 /

-0.15 (-2.37%)

DMTK DermTech
$35.66 /

+7.53 (+26.77%)

AZN AstraZeneca
$50.16 /

+0.26 (+0.52%)

AZN AstraZeneca
$50.16 /

+0.26 (+0.52%)

12/30/20
Fly Intel: Top five analyst calls
12/30/20 AlphaValue
AlphaValue upgrades AstraZeneca, sees sentiment 'finally' improving
12/30/20 AlphaValue
AstraZeneca upgraded to Add from Reduce at AlphaValue
12/29/20 B. Riley
Novavax selloff yesterday brings 'compelling' opportunity, says B. Riley
TSLA Tesla
$694.65 /

+28.67 (+4.30%)

12/31/20
Tesla initiated with a Buy at Masterlink Securities
12/30/20 Wedbush
Tesla should 'handily exceed' delivery expectations, says Wedbush
12/30/20 Credit Suisse
Credit Suisse sees Tesla clearing 2020 target of 500,000 deliveries
12/29/20 GLJ Research
GLJ expects Q4 delivery beat for Tesla but sees 'Bernie Madoff' signs
OSMT Osmotica Pharmaceuticals
$4.22 /

-1.07 (-20.23%)

12/30/20 Truist
Osmotica Pharmaceuticals price target lowered to $8 from $11 at Truist
07/10/20 Truist
Osmotica Pharmaceuticals price target raised to $11 from $8 at SunTrust
07/09/20 RBC Capital
Osmotica price target raised to $12 from $10 at RBC Capital
03/23/20 Wells Fargo
Wells Fargo downgrades Osmotica to Equal Weight, halves price target to $4
MVIS MicroVision
$6.18 /

-0.15 (-2.37%)

05/06/20 Craig-Hallum
MicroVision rise driven by Microsoft speculation, says Craig-Hallum
02/26/20 Craig-Hallum
MicroVision downgraded to Hold from Buy at Craig-Hallum
02/26/20 H.C. Wainwright
MicroVision downgraded to Neutral from Buy at H.C. Wainwright
02/26/20 Ladenburg
Ladenburg downgrades MicroVision to Neutral on lost contract
DMTK DermTech
$35.66 /

+7.53 (+26.77%)

12/14/20 Craig-Hallum
Craig-Hallum bullish on DermTech, initiates with a Buy
12/14/20 Craig-Hallum
DermTech initiated with a Buy at Craig-Hallum
10/29/20 William Blair
DermTech initiated with an Outperform at William Blair
09/11/20
Fly Intel: Top five analyst initiations
TSLA Tesla
$694.65 /

+28.67 (+4.30%)

OSMT Osmotica Pharmaceuticals
$4.22 /

-1.07 (-20.23%)

DMTK DermTech
$35.66 /

+7.53 (+26.77%)

AZN AstraZeneca
$50.16 /

+0.26 (+0.52%)

  • 14
    Jul
  • 14
    Feb
  • 09
    Jan
TSLA Tesla
$694.65 /

+28.67 (+4.30%)

MVIS MicroVision
$6.18 /

-0.15 (-2.37%)

AZN AstraZeneca
$50.16 /

+0.26 (+0.52%)

TSLA Tesla
$694.65 /

+28.67 (+4.30%)

OSMT Osmotica Pharmaceuticals
$4.22 /

-1.07 (-20.23%)

DMTK DermTech
$35.66 /

+7.53 (+26.77%)

AZN AstraZeneca
$50.16 /

+0.26 (+0.52%)

TSLA Tesla
$694.65 /

+28.67 (+4.30%)

MVIS MicroVision
$6.18 /

-0.15 (-2.37%)

DMTK DermTech
$35.66 /

+7.53 (+26.77%)

AZN AstraZeneca
$50.16 /

+0.26 (+0.52%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.